Authors
Loading...
Observational analysis discovered innate resistance mechanisms to EGFR-TKIs in patients with early-stage non-small cell lung cancer, indicating genomic heterogeneity is significant.
Seong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: